Indaptus Therapeutics, Inc.
INDP • NASDAQ • Stock Fundamentals
Indaptus Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Junyi Dai, with a market cap of $125.7M.
Market Cap$125.7M
Employees7.0
CEOJunyi Dai
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 17, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Indaptus Therapeutics, Inc. FAQ
Common questions about Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. (INDP) has a market capitalization of $125.7M and trades on NASDAQ.
Indaptus Therapeutics, Inc. has approximately 7 employees.